Refusal 250 licensed in the Netherlands

After a long period of shortages, Ace guarantees the continuity of the drug Refusal 250 mg tablet by finding a new supplier for the active ingredient and taking over the registration file. Ace has taken over the marketing authorisation from Daleco Pharma BV.

Refusal can be used to support drinking cessation in the treatment of alcoholism. Refusal is packed in a jar containing 30 tablets. One tablet contains 250 mg disulfiram. The tablet has a score line and can be divided into two equal doses.

Refusal is currently only licensed in the Netherlands. For more information about availability outside the Netherlands, please contact us.